Keyphrases
Chronic Lymphocytic Leukemia
91%
Ibrutinib
46%
B-cell Receptor Signaling
29%
Hairy Cell Leukemia
25%
Chronic Lymphocytic Leukemia Cells
24%
CCL3
22%
Bruton Tyrosine Kinase Inhibitor
17%
Quiescence
16%
Transcription Factor
16%
Rituximab
16%
ELF4
15%
Leukemia Cells
14%
Microenvironment
11%
Carbon Tetrachloride
11%
Bone Marrow
11%
Leukemia Patients
11%
Nurse-like Cells
10%
B Cell Receptor
10%
Leukemia Cell Proliferation
10%
New Therapeutic Approaches
10%
Plasma Parameters
10%
Randomized Trial
9%
Tissue Microenvironment
9%
Malignant B Cells
9%
Dual Mechanism of Action
9%
T Follicular Helper Cells
8%
Elderly Patients
8%
Initial Treatment
8%
Level Function
8%
CXCL13
8%
T-bet
8%
Multikinase Inhibitor
8%
High Risk
8%
CXCR4 Chemokine Receptor
8%
Cell Co-culture
8%
Pathway Activation
8%
TG02
8%
Putative Drug Targets
8%
Cell Death
8%
Myeloablative
8%
T-cell Repertoire Diversity
8%
GS-1101
8%
Spleen Tyrosine Kinase Inhibitor
8%
R406
8%
Primitive Hematopoietic Cells
8%
Receptor Function
8%
Induced Apoptosis
8%
Disease Activity
8%
Lenalidomide
8%
PCI-32765
8%
Medicine and Dentistry
B-Cell Chronic Lymphocytic Leukemia
100%
Ibrutinib
60%
Leukemia Cell
53%
B Lymphocyte Receptor
36%
B Cell
25%
Hairy Cell Leukemia
25%
Stromal Cell
19%
Phosphoinositide 3-Kinase
17%
Protein Kinase Syk Inhibitor
17%
Biological Marker
16%
Bone Marrow Stromal Cell
11%
IGHV@
11%
Cell Migration
11%
Chronic Lymphocytic Leukemia
11%
Protein Kinase ZAP 70
10%
Idelalisib
10%
Chemokine
9%
Protein Tyrosine Kinase
9%
Leukemia Survival
9%
Deuterium Oxide
9%
Integrin
9%
Bruton Tyrosine Kinase Inhibitor
9%
Targeted Therapy
9%
microRNA
8%
B Cell Activation
8%
T Cell
8%
Chemokine Receptor CXCR4
8%
Disease Activity
8%
Percutaneous Coronary Intervention
8%
Activation Induced Cytidine Deaminase
8%
Evolution
8%
Rituximab
8%
Diffuse Large B-Cell Lymphoma
8%
Acute B-Cell Lymphoblastic Leukemia
8%
Acute Lymphoblastic Leukemia
8%
Cell Kinetics
8%
Secretion (Process)
6%
Cell Survival
6%
Cell Adhesion
5%
Janus Kinase 1
5%
Adverse Outcome
5%
T Cell Receptor
5%
Immunology and Microbiology
Leukemia Cell
62%
B Cell
43%
B-Cell Receptor
25%
CCL3
21%
Coculture
14%
Cell Adhesion
13%
CXCL13
12%
Chemokine
11%
Immunotherapy
11%
Blood Level
10%
Programmed Cell Death
10%
Cyclophosphamide
10%
T Cell Receptor
10%
Lymph Node
10%
Cell Migration
10%
T Cell
10%
CXCR4
9%
Drug Resistance
9%
Secretion (Process)
8%
Evolution
8%
Follicular B Helper T Cells
8%
Immunoglobulin D
8%
B Cell Activation
8%
Transcription Factor
8%
Chemokine Receptor CXCR4
8%
Cycline
8%
Rituximab
8%
Immunoglobulin M
8%
Activation-Induced Cytidine Deaminase
8%
Blood Vessel
8%
Integrin
8%
Tyrosine
8%
Cell Survival
7%
Cell Cycle
6%
Regulatory T Cell
6%
T Cell Subset
6%
Molecular Interaction
5%
Downregulation
5%
